DOES BENZBROMARONE IN THERAPEUTIC DOSES RAISE RENAL EXCRETION OF OXIPURINOL

被引：12

作者：

MERTZ, DP

EICHHORN, R

机构：

来源：

KLINISCHE WOCHENSCHRIFT | 1984年 / 62卷 / 24期

关键词：

D O I：

10.1007/BF01712184

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

收藏

页码：1170 / &

相关论文

共 8 条

[1]

ARNTZ HR, 1979, FORTSCHR MED, V97, P1212

[2]

KINETICS OF ALLOPURINOL AFTER SINGLE INTRAVENOUS AND ORAL DOSES - NON-INTERACTION WITH BENZBROMARONE AND HYDROCHLOROTHIAZIDE [J].

BREITHAUPT, H ;

TITTEL, M .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (01) :77-84

[3]

RENAL CLEARANCE OF OXIPURINOL CHIEF METABOLITE OF ALLOPURINOL [J].

ELION, GB ;

YU, TF ;

GUTMAN, AB ;

HITCHINGS, GH .

AMERICAN JOURNAL OF MEDICINE, 1968, 45 (01) :69-+

[4]

HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR ALLOPURINOL AND OXIPURINOL IN HUMAN-PLASMA [J].

KRAMER, WG ;

FELDMAN, S .

JOURNAL OF CHROMATOGRAPHY, 1979, 162 (01) :94-97

[5]

GOUT AND URIC-ACID NEPHROPATHY - SOME NEW ASPECTS IN DIAGNOSIS AND TREATMENT [J].

LOFFLER, W ;

SIMMONDS, HA ;

GROBNER, W .

KLINISCHE WOCHENSCHRIFT, 1983, 61 (24) :1233-1239

[6]

TREATMENT OF HYPERURICEMIA WITH A COMBINATION OF ALLOPURINOL AND BENZBROMARON [J].

MATZKIES, F ;

BERG, G .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1976, 101 (43) :1568-1570

[7]

REDUCING RISKS IN TREATMENT OF GOUT AND HYPERURICEMIA [J].

MERTZ, DP .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1976, 101 (35) :1288-1292

[8]

MERTZ DP, 1983, MED WELT, V34, P974